Duplicate publication

Comment

Jack J Chen. Am J Health Syst Pharm. 2006.

. 2006 Dec 1;63(23):2310.

doi: 10.2146/ajhp060514.

No abstract available

Comment on

Clinical pharmacology of rasagiline: a novel, second-generation propargylamine for the treatment of Parkinson disease.
Chen JJ, Swope DM. Chen JJ, et al. J Clin Pharmacol. 2005 Aug;45(8):878-94. doi: 10.1177/0091270005277935. J Clin Pharmacol. 2005. PMID: 16027398 Review.
Rasagiline: A second-generation monoamine oxidase type-B inhibitor for the treatment of Parkinson's disease.
Chen JJ, Ly AV. Chen JJ, et al. Am J Health Syst Pharm. 2006 May 15;63(10):915-28. doi: 10.2146/ajhp050395. Am J Health Syst Pharm. 2006. PMID: 16675649 Review.